Open session

10:00 // João Moura (P-BIO Board and BIOCANT President)


Clinical Development

10:15 // Public presentation of the study “Clinical Development Road Map” – Francisco Batel Marques (AIBILI – “Technology Assessment Center for Health Research and Medicines” Director) – responsible for the study


11:00 – 11:15 // Coffee Break

11:15 – 12:30 // “Clinical Development Road Map” study debate

Moderation of the debate: Francisco Batel Marques (responsible for the study)

Sérgio Simões – Blueclinical and P-BIO board

Aleixo Dias – PFZIER Medical Director

João Pereira – Magnomics Chief Executive Office

Alexandre Lourenço – Portuguese Hospital Managers Association President

INFARMED I.P. “National Authority of Medicines and Health Products” board member to designate (tbc)

13:00 // Lunch – with prior registration


Location: BIOCANT ½ day (Morning and lunch)


Side event // BIOCANT Junior Science Center


Register for free by September 23: